MOECX Performance — NYLI Growth ETF Allocation Fund, Class C
Data updated: 2026-09-23
MOECX returned +9.34% year to date and +17.75% over one year to Jul 2026. Annualised returns are +12.96% over 3 years and +7.16% over 5 years. Against its Alternative category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $144, against $168 for the category, and to $118 over one year, against $108. Volatility over the past three years was 11.14% a year. In the 12 months to Jul 2026 the fund took in a net $24.7M, and assets reached $199.94M.
MOECX Growth of $100
What $100 invested in NYLI Growth ETF Allocation Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Alternative category average over the same months.
| Period | MOECX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $118 | $108 |
| 3 years (Aug 2023 – Jul 2026) | $144 | $168 |
| 5 years (Aug 2021 – Jul 2026) | $141 | $159 |
| Since data start (Jul 2020 – Jul 2026) | $185 | $189 |
MOECX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.34% |
| 1 year | +17.75% |
| 3 years (annualised) | +12.96% |
| 5 years (annualised) | +7.16% |
MOECX Annual Returns
Calendar-year total returns of NYLI Growth ETF Allocation Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +9.34% |
| 2025 | +15.06% |
| 2024 | +11.42% |
| 2023 | +15.55% |
| 2022 | −15.52% |
| 2021 | +14.20% |
| 2020 (Jul–Dec) | +18.38% |
MOECX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.5% | +1.2% | −5.0% | +7.7% | +3.7% | +0.6% | −1.3% | — | — | — | — | — |
| 2025 | +2.6% | −1.5% | −3.4% | +0.1% | +4.6% | +3.6% | +0.9% | +2.4% | +2.7% | +1.5% | +0.4% | +0.5% |
| 2024 | −0.2% | +3.0% | +2.8% | −3.9% | +3.8% | +0.9% | +2.6% | +1.4% | +2.1% | −1.7% | +4.7% | −4.2% |
| 2023 | +6.4% | −2.3% | +0.8% | +0.5% | −1.5% | +5.3% | +2.9% | −2.4% | −4.1% | −3.1% | +7.7% | +5.3% |
| 2022 | −5.0% | −1.5% | +1.5% | −6.9% | +0.5% | −8.0% | +7.1% | −3.5% | −8.0% | +7.0% | +5.8% | −4.1% |
| 2021 | −0.3% | +2.2% | +2.4% | +3.4% | +1.3% | +0.5% | +0.6% | +1.7% | −3.5% | +4.4% | −2.5% | +3.5% |
| 2020 | — | — | — | — | — | — | +4.2% | +4.2% | −2.5% | −1.8% | +9.7% | +3.8% |
MOECX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 11.14%
- 3-year Sharpe ratio: 0.76 (vs 4.5% risk-free rate)
- Best month: +7.74% (Apr 2026)
- Worst month: −5.02% (Mar 2026)
MOECX Fund Flows
Monthly money in and out of NYLI Growth ETF Allocation Fund, from SEC Form N-PORT.
- 12-month net flow: $24.7M
- 12-month gross sales (incl. reinvestments): $51.1M
- Sales ÷ redemptions: 1.94×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.7M | $2.3M | $2.3M |
| Jun 2026 | $4.5M | $2.7M | $1.8M |
| May 2026 | $3.3M | $1.8M | $1.5M |
| Apr 2026 | $4.5M | $3.2M | $1.3M |
| Mar 2026 | $4.0M | $2.7M | $1.3M |
| Feb 2026 | $3.3M | $1.9M | $1.4M |
| Jan 2026 | $3.9M | $2.6M | $1.3M |
| Dec 2025 | $9.6M | $1.8M | $7.8M |
| Nov 2025 | $2.8M | $2.2M | $518K |
| Oct 2025 | $3.2M | $2.0M | $1.3M |
| Sep 2025 | $3.7M | $1.6M | $2.1M |
| Aug 2025 | $3.6M | $1.6M | $2.0M |
MOECX Assets Under Management
Net assets of NYLI Growth ETF Allocation Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $199.94M |
| 2026-04-30 | $188.42M |
| 2026-01-31 | $177.50M |
| 2025-10-31 | $167.23M |
| 2025-07-31 | $151.19M |
| 2025-04-30 | $134.64M |
| 2025-01-31 | $135.03M |
| 2024-10-31 | $127.16M |
| 2024-07-31 | $120.78M |
| 2024-04-30 | $108.28M |
| 2024-01-31 | $101.84M |
| 2023-10-31 | $86.01M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.